158 related articles for article (PubMed ID: 10024885)
1. Insertion of excised IgH switch sequences causes overexpression of cyclin D1 in a myeloma tumor cell.
Gabrea A; Bergsagel PL; Chesi M; Shou Y; Kuehl WM
Mol Cell; 1999 Jan; 3(1):119-23. PubMed ID: 10024885
[TBL] [Abstract][Full Text] [Related]
2. Dysregulation of cyclin D1 by translocation into an IgH gamma switch region in two multiple myeloma cell lines.
Chesi M; Bergsagel PL; Brents LA; Smith CM; Gerhard DS; Kuehl WM
Blood; 1996 Jul; 88(2):674-81. PubMed ID: 8695815
[TBL] [Abstract][Full Text] [Related]
3. Genomic characterization of the chromosomal breakpoints of t(4;14) of multiple myeloma suggests more than one possible aetiological mechanism.
Fenton JA; Pratt G; Rawstron AC; Sibley K; Rothwell D; Yates Z; Dring A; Richards SJ; Ashcroft AJ; Davies FE; Owen RG; Child JA; Morgan GJ
Oncogene; 2003 Feb; 22(7):1103-13. PubMed ID: 12592397
[TBL] [Abstract][Full Text] [Related]
4. [Long distance vectorette PCR for detecting translocation of IgH gene in switch regions of patients with multiple myeloma].
Guo C; Huo J; Jiang H
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Jun; 13(3):460-3. PubMed ID: 15972142
[TBL] [Abstract][Full Text] [Related]
5. Promiscuous translocations into immunoglobulin heavy chain switch regions in multiple myeloma.
Bergsagel PL; Chesi M; Nardini E; Brents LA; Kirby SL; Kuehl WM
Proc Natl Acad Sci U S A; 1996 Nov; 93(24):13931-6. PubMed ID: 8943038
[TBL] [Abstract][Full Text] [Related]
6. IgH translocations in multiple myeloma: a nearly universal event that rarely involves c-myc.
Bergsagel PL; Nardini E; Brents L; Chesi M; Kuehl WM
Curr Top Microbiol Immunol; 1997; 224():283-7. PubMed ID: 9308253
[TBL] [Abstract][Full Text] [Related]
7. Cyclin D3 at 6p21 is dysregulated by recurrent chromosomal translocations to immunoglobulin loci in multiple myeloma.
Shaughnessy J; Gabrea A; Qi Y; Brents L; Zhan F; Tian E; Sawyer J; Barlogie B; Bergsagel PL; Kuehl M
Blood; 2001 Jul; 98(1):217-23. PubMed ID: 11418483
[TBL] [Abstract][Full Text] [Related]
8. The t(11;14) (q13;q32) in multiple myeloma cell line KMS12 has its 11q13 breakpoint 330 kb centromeric from the cyclin D1 gene.
Vaandrager JW; Kluin P; Schuuring E
Blood; 1997 Jan; 89(1):349-50. PubMed ID: 8978314
[No Abstract] [Full Text] [Related]
9. Translocation t(11;14) in multiple myeloma: Analysis of translocation breakpoints on der(11) and der(14) chromosomes suggests complex molecular mechanisms of recombination.
Fenton JA; Pratt G; Rothwell DG; Rawstron AC; Morgan GJ
Genes Chromosomes Cancer; 2004 Feb; 39(2):151-5. PubMed ID: 14695995
[TBL] [Abstract][Full Text] [Related]
10. Characterization of oncogene dysregulation in multiple myeloma by combined FISH and DNA microarray analyses.
Fabris S; Agnelli L; Mattioli M; Baldini L; Ronchetti D; Morabito F; Verdelli D; Nobili L; Intini D; Callea V; Stelitano C; Lombardi L; Neri A
Genes Chromosomes Cancer; 2005 Feb; 42(2):117-27. PubMed ID: 15543617
[TBL] [Abstract][Full Text] [Related]
11. Light-chain only multiple myeloma is due to the absence of functional (productive) rearrangement of the IgH gene at the DNA level.
Magrangeas F; Cormier ML; Descamps G; Gouy N; Lodé L; Mellerin MP; Harousseau JL; Bataille R; Minvielle S; Avet-Loiseau H
Blood; 2004 May; 103(10):3869-75. PubMed ID: 14715636
[TBL] [Abstract][Full Text] [Related]
12. Various patterns of IgH deletion identified by FISH using combined IgH and IgH/CCND1 probes in multiple myeloma and chronic lymphocytic leukemia.
Hwang Y; Lee JY; Mun YC; Seong CM; Chung WS; Huh J
Int J Lab Hematol; 2011 Jun; 33(3):299-304. PubMed ID: 21272268
[TBL] [Abstract][Full Text] [Related]
13. Concurrent activation of a novel putative transforming gene, myeov, and cyclin D1 in a subset of multiple myeloma cell lines with t(11;14)(q13;q32).
Janssen JW; Vaandrager JW; Heuser T; Jauch A; Kluin PM; Geelen E; Bergsagel PL; Kuehl WM; Drexler HG; Otsuki T; Bartram CR; Schuuring E
Blood; 2000 Apr; 95(8):2691-8. PubMed ID: 10753852
[TBL] [Abstract][Full Text] [Related]
14. Isolation and characterisation of recombination events involving immunoglobulin heavy chain switch regions in multiple myeloma using long distance vectorette PCR (LDV-PCR).
Proffitt J; Fenton J; Pratt G; Yates Z; Morgan G
Leukemia; 1999 Jul; 13(7):1100-7. PubMed ID: 10400427
[TBL] [Abstract][Full Text] [Related]
15. Frequent translocation t(4;14)(p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3.
Chesi M; Nardini E; Brents LA; Schröck E; Ried T; Kuehl WM; Bergsagel PL
Nat Genet; 1997 Jul; 16(3):260-4. PubMed ID: 9207791
[TBL] [Abstract][Full Text] [Related]
16. Correlation between losses of IGH or its segments and deletions of 13q14 in t(11;14) (q13;q32) multiple myeloma.
Trakhtenbrot L; Hardan I; Koren-Michowitz M; Oren S; Yshoev G; Rechavi G; Nagler A; Amariglio N
Genes Chromosomes Cancer; 2010 Jan; 49(1):17-27. PubMed ID: 19787791
[TBL] [Abstract][Full Text] [Related]
17. Chromosome translocations in multiple myeloma.
Bergsagel PL; Kuehl WM
Oncogene; 2001 Sep; 20(40):5611-22. PubMed ID: 11607813
[TBL] [Abstract][Full Text] [Related]
18. Frequent occurrence of CCND1 deregulation in patients with early stages of plasma cell dyscrasia.
Miura K; Iida S; Hanamura I; Kato M; Banno S; Ishida T; Kusumoto S; Takeuchi G; Miwa H; Nitta M; Inagaki H; Eimoto T; Nomura K; Taniwaki M; Ueda R
Cancer Sci; 2003 Apr; 94(4):350-4. PubMed ID: 12824903
[TBL] [Abstract][Full Text] [Related]
19. Chromosomal translocation t(11;14) and p53 deletion induced by the CRISPR/Cas9 system in normal B cell-derived iPS cells.
Azami Y; Tsuyama N; Abe Y; Sugai-Takahashi M; Kudo KI; Ota A; Sivasundaram K; Muramatsu M; Shigemura T; Sasatani M; Hashimoto Y; Saji S; Kamiya K; Hanamura I; Ikezoe T; Onodera M; Sakai A
Sci Rep; 2021 Mar; 11(1):5216. PubMed ID: 33664418
[TBL] [Abstract][Full Text] [Related]
20. Identification of two distinct MYC breakpoint clusters and their association with various IGH breakpoint regions in the t(8;14) translocations in sporadic Burkitt-lymphoma.
Busch K; Keller T; Fuchs U; Yeh RF; Harbott J; Klose I; Wiemels J; Novosel A; Reiter A; Borkhardt A
Leukemia; 2007 Aug; 21(8):1739-51. PubMed ID: 17541401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]